raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:65287

Beta-ureidopropionase deficiency

Synonyms: Beta-alanine synthase deficiency

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Infancy, Neonatal
Status
active

Beta-ureidopropionase deficiency is a very rare pyrimidine metabolism disorder described in fewer than 10 patients to date with an extremely wide clinical picture ranging from asymptomatic cases to neurological (epilepsy, autism) and developmental disorders (urogenital, colorectal).

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enBeta-ureidopropionase deficiencyBeta-alanine synthase deficiency
frDéficit en bêta-uréidopropionaseDéficit en bêta-alanine synthase
deBeta-Ureidopropionase-MangelBeta-Alanin-Synthase-Mangel
esDeficiencia de beta-ureidopropionasaDeficiencia de beta-alanina sintasa · Deficiencia de beta-alanina sintetasa
itDeficit di beta-ureidopropionasiDeficit di beta-alanina sintasi
nlDeficiëntie van bèta-ureïdopropionaseDeficiëntie van bèta-alaninesynthase
ptDeficiência de beta-ureidopropionaseDeficiência de beta-alanina sintase
plNiedobór beta-ureidopropionazyNiedobór syntazy beta-alaninowej
csDeficit beta-ureidopropionázyDeficit beta-alanin syntázy
ukДефіцит бета-уреїдопропіоназиДефіцит бета-аланінсинтетази
zhβ-脲基丙酸酶缺乏症β-丙氨酸合酶缺乏症
trBeta-üreidopropionaz eksikliğiBeta-alanin sentaz eksikliği

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM613161Evalidated
ICD-10E79.8NTBTattributedvalidated
ICD-115C55.1NTBTindexvalidated
MONDO0013164Evalidated
MeSHC563210Evalidated
UMLSC1291512Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
UPB1Disease-causing germline mutation(s) inAssessedHGNC:16297ENSG0000010002460667322q11.23beta-ureidopropionase 115385443[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families5 casesWorldwideCase(s)Validated17964839[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_17964839[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

16 annotations · validated 2025-07-23
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:6000279Elevated urinary N-carbamoyl-beta-alanine level
HP:6000623Elevated urinary N-carbamyl-beta-aminoisobutyric acid level
HP:6000119Elevated urinary dihydrothymine level
HP:6000118Elevated urinary dihydrouracil level
HP:0001263Global developmental delay
HP:0001252Hypotonia
HP:0001249Intellectual disability
HP:6000082Reduced hepatic beta-ureidopropionase activity
HP:0001250Seizure
Occasional (29-5%)
HP:0000717Autism
HP:0002059Cerebral atrophy
HP:0002539Cortical dysplasia
HP:0012448Delayed myelination
HP:0000750Delayed speech and language development
HP:0001510Growth delay
HP:0000252Microcephaly

Annotation source: 30608453[PMID]_22525402[PMID]_25638458[PMID]_24526388[PMID]_18853477[PMID]

7

Sources for this card